188 related articles for article (PubMed ID: 9532176)
1. Islet cell autoimmunity in NOD mice transgenic for HLA-DQ8 and lacking I-Ag7.
Raju R; Munn SR; Majoribanks C; David CS
Transplant Proc; 1998 Mar; 30(2):561. PubMed ID: 9532176
[No Abstract] [Full Text] [Related]
2. Islet cell autoimmunity in NOD mice transgenic to HLA-DQ8 and lacking I-Ag7.
Raju R; Munn SR; Majoribanks C; David CS
Transplant Proc; 1998 Mar; 30(2):474. PubMed ID: 9532134
[No Abstract] [Full Text] [Related]
3. Human DQ8 can substitute for murine I-Ag7 in the selection of diabetogenic T cells restricted to I-Ag7.
Wen L; Wong FS; Sherwin R; Mora C
J Immunol; 2002 Apr; 168(7):3635-40. PubMed ID: 11907129
[TBL] [Abstract][Full Text] [Related]
4. [Mechanism and genetic control of the autoimmune response directed against beta-pancreatic cells in insulin-dependent diabetes].
Michelsen B; Baekkeskov S; Deufel T; Kastern W; Kofod H; Lernmark A; Vissing H
Journ Annu Diabetol Hotel Dieu; 1985; ():171-82. PubMed ID: 2577960
[No Abstract] [Full Text] [Related]
5. Major DQ8-restricted T-cell epitopes for human GAD65 mapped using human CD4, DQA1*0301, DQB1*0302 transgenic IA(null) NOD mice.
Liu J; Purdy LE; Rabinovitch S; Jevnikar AM; Elliott JF
Diabetes; 1999 Mar; 48(3):469-77. PubMed ID: 10078545
[TBL] [Abstract][Full Text] [Related]
6. The murine diabetogenic class II histocompatibility molecule I-Ag7: structural and functional properties and specificity of peptide selection.
Suri A; Unanue ER
Adv Immunol; 2005; 88():235-65. PubMed ID: 16227092
[TBL] [Abstract][Full Text] [Related]
7. NOD background genes influence T cell responses to GAD 65 in HLA-DQ8 transgenic mice.
Abraham RS; Wilson SB; de Souza NF; Strominger JL; Munn SR; David CS
Hum Immunol; 1999 Jul; 60(7):583-90. PubMed ID: 10426275
[TBL] [Abstract][Full Text] [Related]
8. Prevention of diabetes in NOD mice by a mutated I-Ab transgene.
Singer SM; Tisch R; Yang XD; Sytwu HK; Liblau R; McDevitt HO
Diabetes; 1998 Oct; 47(10):1570-7. PubMed ID: 9753294
[TBL] [Abstract][Full Text] [Related]
9. I-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet beta cells of nonobese diabetic mice.
Noorchashm H; Lieu YK; Noorchashm N; Rostami SY; Greeley SA; Schlachterman A; Song HK; Noto LE; Jevnikar AM; Barker CF; Naji A
J Immunol; 1999 Jul; 163(2):743-50. PubMed ID: 10395666
[TBL] [Abstract][Full Text] [Related]
10. Induction of insulitis by glutamic acid decarboxylase peptide-specific and HLA-DQ8-restricted CD4(+) T cells from human DQ transgenic mice.
Wen L; Wong FS; Burkly L; Altieri M; Mamalaki C; Kioussis D; Flavell RA; Sherwin RS
J Clin Invest; 1998 Sep; 102(5):947-57. PubMed ID: 9727063
[TBL] [Abstract][Full Text] [Related]
11. Modulation of insulitis and type 1 diabetes by transgenic HLA-DR3 and DQ8 in NOD mice lacking endogenous MHC class II.
Kudva YC; Rajagopalan G; Raju R; Abraham RS; Smart M; Hanson J; David CS
Hum Immunol; 2002 Nov; 63(11):987-99. PubMed ID: 12392851
[TBL] [Abstract][Full Text] [Related]
12. Autoimmune diabetes in HLA-DR3/DQ8 transgenic mice expressing the co-stimulatory molecule B7-1 in the beta cells of islets of Langerhans.
Rajagopalan G; Kudva YC; Chen L; Wen L; David CS
Int Immunol; 2003 Sep; 15(9):1035-44. PubMed ID: 12917255
[TBL] [Abstract][Full Text] [Related]
13. HLA-DQ8-associated T cell responses to the diabetes autoantigen phogrin (IA-2 beta) in human prediabetes.
Kelemen K; Gottlieb PA; Putnam AL; Davidson HW; Wegmann DR; Hutton JC
J Immunol; 2004 Mar; 172(6):3955-62. PubMed ID: 15004204
[TBL] [Abstract][Full Text] [Related]
14. Structure of a human insulin peptide-HLA-DQ8 complex and susceptibility to type 1 diabetes.
Lee KH; Wucherpfennig KW; Wiley DC
Nat Immunol; 2001 Jun; 2(6):501-7. PubMed ID: 11376336
[TBL] [Abstract][Full Text] [Related]
15. The regulatory role of DR4 in a spontaneous diabetes DQ8 transgenic model.
Wen L; Chen NY; Tang J; Sherwin R; Wong FS
J Clin Invest; 2001 Apr; 107(7):871-80. PubMed ID: 11285306
[TBL] [Abstract][Full Text] [Related]
16. Co-expression of HLA DR3 and DQ8 results in the development of spontaneous insulitis and loss of tolerance to GAD65 in transgenic mice.
Abraham RS; Kudva YC; Wilson SB; Strominger JL; David CS
Diabetes; 2000 Apr; 49(4):548-54. PubMed ID: 10871191
[TBL] [Abstract][Full Text] [Related]
17. Biochemical characterization of the human diabetes-associated HLA-DQ8 allelic product: similarity to the major histocompatibility complex class II I-A(g)7 protein of non-obese diabetic mice.
Reizis B; Altmann DM; Cohen IR
Eur J Immunol; 1997 Oct; 27(10):2478-83. PubMed ID: 9368599
[TBL] [Abstract][Full Text] [Related]
18. Accelerated diabetes in rat insulin promoter-tumor necrosis factor-alpha transgenic nonobese diabetic mice lacking major histocompatibility class II molecules.
Rajagopalan G; Kudva YC; Flavell RA; David CS
Diabetes; 2003 Feb; 52(2):342-7. PubMed ID: 12540606
[TBL] [Abstract][Full Text] [Related]
19. Class II HLA Genotype Association With First-Phase Insulin Response Is Explained by Islet Autoantibodies.
Koskinen MK; Lempainen J; Löyttyniemi E; Helminen O; Hekkala A; Härkönen T; Kiviniemi M; Simell O; Knip M; Ilonen J; Toppari J; Veijola R
J Clin Endocrinol Metab; 2018 Aug; 103(8):2870-2878. PubMed ID: 29300921
[TBL] [Abstract][Full Text] [Related]
20. Autoimmunity in HLA-DQ8 transgenic mice expressing granulocyte/macrophage-colony stimulating factor in the beta cells of islets of Langerhans.
Rajagopalan G; Mangalam AK; Sen MM; Cheng S; Kudva YC; David CS
Autoimmunity; 2007 May; 40(3):169-79. PubMed ID: 17453715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
